March 11, 2021
Takeda Pharmaceutical is exercising its option to snap up US biotech Maverick Therapeutics for up to US$525 million in a bid to enrich its immuno-oncology portfolio with T-cell engager therapies for solid tumors. In January 2017, the two companies inked...read more